Articles by Riley Griffin | Fortune

Skip to Content

SIGN IN

Health
Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
By
Riley Griffin
and
Bloomberg
November 10, 2020
International
Germany funded the development of Pfizer’s COVID vaccine—not U.S.’s Operation Warp Speed
By
Riley Griffin,
Drew Armstrong,
and others
November 10, 2020
Health
Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
By
Robert Langreth,
Naomi Kresge,
and others
November 9, 2020
International
Some scientists downplay significance of AstraZeneca’s COVID-19 vaccine trial halt
By
Michelle Fay Cortez,
Riley Griffin,
and others
September 9, 2020
Health
Anthony Fauci says coronavirus vaccine immunity is likely to be ‘finite’
By
Riley Griffin
and
Bloomberg
July 7, 2020
Health
Dr. Fauci’s worst nightmare? We’re living it
By
John Lauerman,
Riley Griffin,
and others
June 10, 2020
International
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By
James Paton,
Riley Griffin,
and others
May 26, 2020
Health
‘Pharma bro’ Martin Shkreli sued for alleged violation of antitrust law
By
Erik Larson,
Riley Griffin,
and others
January 27, 2020
Health
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
By
Riley Griffin,
James Paton,
and others
December 9, 2019
Health
Sackler Family Backs $11B Settlement of Opioid Lawsuits That Would See Purdue Pharma File for Bankruptcy
By
Jef Feeley,
Riley Griffin,
and others
August 28, 2019
Health
J&J Shares Rise After Lower Than Expected Award for Company’s Part in Opioid Crisis
By
Jef Feeley,
Riley Griffin,
and others
August 27, 2019

1 - 11 of 11 results

1 - 11 of 11 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.